Nicholas Silvestri, MD
Neuromuscular Medicine · Buffalo, NYNPI 1073783858
Payments from drug & device makers
Across 628 payments — averaging $1119.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Argenx US, Inc.$201K
- AstraZeneca$196K
- UCB, Inc.$115K
- UCB SA$78K
- Johnson & Johnson$23K
- Amgen$14K
- plus $76K from 27 others
Across 7 payments — averaging $1589.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$11K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Argenx US, Inc. | 177 | $200,915 |
| AstraZeneca | 190 | $195,851 |
| UCB, Inc. | 115 | $115,098 |
| UCB SA | 21 | $78,486 |
| Johnson & Johnson(2 entities) | 19 | $22,920 |
| Amgen(2 entities) | 14 | $13,922 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $11,603 |
| Janssen Scientific Affairs, LLC | 7 | $11,160 |
| Janssen Research & Development, LLC | 1 | $7,875 |
| F. Hoffmann-la Roche AG | 4 | $7,603 |
| Strongbridge US Inc. | 7 | $5,768 |
| Genentech USA, Inc. | 2 | $4,565 |
| Xeris Pharmaceuticals, Inc. | 4 | $4,067 |
| Genentech, Inc. | 2 | $3,934 |
| Biogen | 7 | $3,736 |
| Regeneron | 2 | $3,500 |
| Sarepta Therapeutics, Inc. | 3 | $3,078 |
| Janssen Global Services, LLC | 2 | $2,910 |
| Merck Kgaa | 1 | $2,480 |
| Vertex | 7 | $2,375 |
| CSL Behring | 8 | $214 |
| Pfizer | 7 | $153 |
| AbbVie | 5 | $122 |
| Sanofi | 2 | $80 |
| Ipsen Biopharmaceuticals, Inc | 2 | $73 |
| Neurocrine Biosciences, Inc. | 3 | $65 |
| Eisai Inc. | 2 | $64 |
| Grifols USA, LLC | 2 | $51 |
| Novartis | 2 | $46 |
| EMD Serono, Inc. | 1 | $29 |
| NS Pharma, Inc. | 1 | $27 |
| Acorda Therapeutics, Inc | 1 | $21 |
| PTC Therapeutics, Inc. | 1 | $19 |
How this compares
$702,809 in reported general payments places this provider in the 95th percentile of 25 neuromuscular medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neuromuscular medicine in Buffalo
- Alexander BaderBuffalo$838
- Peter CreighRochester$340K
- Thurman WheelerRochester$271K
- Luisa RojasAmherst$246K
- Patrick KwonBrooklyn$188K
- Jenny MeyerSyracuse$135K
- Ikjae LeeNew York$31K
- Leslie DelfinerBronx$12K
- Samuel MackenzieRochester$12K
- David OberSuffern$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.